ENGLEWOOD, Colo., Sept. 21, 2017 /PRNewswire/ — Since its inception, Paragon 28 has obsessed over every aspect of foot and ankle surgery. Committed to creating tailored solutions to improve surgical outcomes, Paragon 28 has launched innovative products and instrumentation that help to streamline procedures, allow surgeons flexibility in technique and approach, and facilitate […]
All News
September 20, 2017 HOUSTON–(BUSINESS WIRE)–SpinalCyte, LLC, a Texas-based tissue engineering technology company focused on regrowth of the spinal disc nucleus using human dermal fibroblasts, announced today the issuance of Australian Patent No. 2015202319, “Methods And Compositions For Repair of Cartilage Using An In Vivo Bioreactor.” The technology described in the […]
SUNNYVALE, Calif., Sept. 19, 2017 (GLOBE NEWSWIRE) — Relievant Medsystems, a privately held medical device company that has developed the Intracept® Procedure, a minimally invasive and clinically proven approach for the treatment of chronic low back pain, announced today that Kevin Hykes has been appointed President and Chief Executive Officer as […]
20-Sep-2017 Lund, Sweden, 08.00 CEST, 20 September 2017 – BONESUPPORT an emerging leader in innovative injectable bio-ceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery based on its unique CERAMENT platform announces that a pre-clinical study evaluating the in-vivo release kinetics of radio-labelled […]
Gosselies, Belgium, 20 September 2017, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, today announces positive interim efficacy results in the Phase I/IIA delayed-union study of its allogeneic bone cell therapy product ALLOB® in 16 […]
September 20, 2017 IRVINE, Calif.–(BUSINESS WIRE)–Irvine, California-based Biogennix, an osteobiologic company which develops, manufactures, and distributes proprietary bone graft substitutes used for bone fusion procedures, announced today that its products have now been used in more than 6000 patients. The company’s novel bone graft substitutes, osteoSPAN™ and Morpheus™ are resorbable, […]
© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.4